Linda Schwartz

754 total citations
17 papers, 574 citations indexed

About

Linda Schwartz is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Linda Schwartz has authored 17 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in Linda Schwartz's work include Occupational and environmental lung diseases (4 papers), Cardiac pacing and defibrillation studies (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Linda Schwartz is often cited by papers focused on Occupational and environmental lung diseases (4 papers), Cardiac pacing and defibrillation studies (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Linda Schwartz collaborates with scholars based in United States, Canada and Mexico. Linda Schwartz's co-authors include Carlos Santos‐Burgoa, G. M. Matanoski, Genevieve M. Matanoski, Scott L. Zeger, Gary L. Gadbury, Radha Murugesan, Stanley Heshka, Steven B. Heymsfield, Kevin R. Fontaine and David B. Allison and has published in prestigious journals such as Journal of the American College of Cardiology, PEDIATRICS and American Journal of Epidemiology.

In The Last Decade

Linda Schwartz

15 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda Schwartz United States 12 200 119 95 88 84 17 574
Frazer Lowe United Kingdom 16 110 0.6× 195 1.6× 73 0.8× 154 1.8× 47 0.6× 25 598
Yuzo Kayamori Japan 14 48 0.2× 74 0.6× 53 0.6× 206 2.3× 90 1.1× 54 676
Laura Rosana Aballay Argentina 15 44 0.2× 67 0.6× 225 2.4× 77 0.9× 50 0.6× 41 616
Mao-wen Weng United States 8 125 0.6× 101 0.8× 43 0.5× 224 2.5× 11 0.1× 8 537
Stuart J. Smith United States 10 67 0.3× 74 0.6× 49 0.5× 62 0.7× 43 0.5× 18 480
Demetrius Albanes United States 16 89 0.4× 41 0.3× 238 2.5× 145 1.6× 32 0.4× 26 1.0k
P. van’t Veer Netherlands 14 101 0.5× 70 0.6× 407 4.3× 161 1.8× 50 0.6× 23 1.0k
Jung Ran Choi South Korea 13 30 0.1× 42 0.4× 78 0.8× 96 1.1× 73 0.9× 34 472
Laudina Rodríguez Spain 10 58 0.3× 154 1.3× 52 0.5× 55 0.6× 24 0.3× 14 454
Jong‐Won Kang South Korea 13 138 0.7× 135 1.1× 26 0.3× 208 2.4× 9 0.1× 29 618

Countries citing papers authored by Linda Schwartz

Since Specialization
Citations

This map shows the geographic impact of Linda Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Schwartz more than expected).

Fields of papers citing papers by Linda Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Schwartz. The network helps show where Linda Schwartz may publish in the future.

Co-authorship network of co-authors of Linda Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Schwartz. A scholar is included among the top collaborators of Linda Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Schwartz. Linda Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
O’Shea, Michael, Saravanan Arunachalam, Ahmed Ibrahim Ahmed, et al.. (2025). The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy. American Heart Journal. 289. 28–37.
2.
Desai, Chirag S., et al.. (2025). Lean Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Clinical Gastroenterology.
3.
Liu, Michael B., et al.. (2022). Safety of magnetic resonance imaging in patients with cardiac implantable electronic devices with generator and lead(s) brand mismatch. Journal of Applied Clinical Medical Physics. 23(3). e13520–e13520. 2 indexed citations
4.
Pike, Jamison, Paul A. Gastañaduy, Meagan Kay, et al.. (2021). Societal Costs of a Measles Outbreak. PEDIATRICS. 147(4). 13 indexed citations
5.
Schwartz, Linda, et al.. (2016). Safety and interaction of patients with implantable cardiac defibrillators driving a hybrid vehicle. International Journal of Cardiology. 227. 318–324. 11 indexed citations
6.
Schwartz, Linda, et al.. (2013). HYBRID CARS AND ICDS: IS IT SAFE?. Journal of the American College of Cardiology. 61(10). E285–E285. 1 indexed citations
7.
Sunderji, Rubina, Kenneth Gin, Karen Shalansky, et al.. (2005). Clinical Impact of Point-of-Care vs Laboratory Measurement of Anticoagulation. American Journal of Clinical Pathology. 123(2). 184–188. 24 indexed citations
8.
Sunderji, Rubina, Kenneth Gin, Karen Shalansky, et al.. (2004). A randomized trial of patient self-managed versus physician-managed oral anticoagulation.. PubMed. 20(11). 1117–23. 52 indexed citations
9.
Allison, David B., Gary L. Gadbury, Linda Schwartz, et al.. (2003). A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. European Journal of Clinical Nutrition. 57(4). 514–522. 124 indexed citations
10.
Fontaine, Kevin R., Dongyan Yang, Gary L. Gadbury, et al.. (2003). Results of soy-based meal replacement formula on weight, anthropometry, serum lipids & blood pressure during a 40-week clinical weight loss trial. Nutrition Journal. 2(1). 14–14. 26 indexed citations
11.
Jewesson, Peter J., Anthony W. Chow, Luciana Frighetto, et al.. (1997). A double-blind, randomized study of three antimicrobial regimens in the prevention of infections after elective colorectal surgery. Diagnostic Microbiology and Infectious Disease. 29(3). 155–165. 14 indexed citations
12.
Jewesson, Peter J., Grant Stiver, Luciana Frighetto, et al.. (1996). Double-blind comparison of cefazolin and ceftizoxime for prophylaxis against infections following elective biliary tract surgery. Antimicrobial Agents and Chemotherapy. 40(1). 70–74. 14 indexed citations
13.
Matanoski, Genevieve, et al.. (1993). Cancer epidemiology among styrene-butadiene rubber workers.. PubMed. 363–74. 28 indexed citations
14.
Santos‐Burgoa, Carlos, G. M. Matanoski, Scott L. Zeger, & Linda Schwartz. (1992). Lymphohematopoietic Cancer in Styrene-Butadiene Polymerization Workers. American Journal of Epidemiology. 136(7). 843–854. 94 indexed citations
15.
Matanoski, G. M., Carlos Santos‐Burgoa, & Linda Schwartz. (1990). Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943-1982).. Environmental Health Perspectives. 86. 107–117. 106 indexed citations
16.
Matanoski, Genevieve M., Carlos Santos‐Burgoa, & Linda Schwartz. (1990). Mortality of a Cohort of Workers in the Styrene-Butadiene Polymer Manufacturing Industry (1943-1982). Environmental Health Perspectives. 86. 107–107. 16 indexed citations
17.
Matanoski, Genevieve M. & Linda Schwartz. (1987). Mortality of workers in styrene-butadiene polymer production.. PubMed. 29(8). 675–80. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026